World Health Organization approval of AstraZeneca vaccine

The World Health Organization has approved the emergency use of the AstraZeneca vaccine.

The World Health Organization has approved the use of the Covid-19 vaccine, developed by the University of AstraZeneca / Oxford, for emergency use, to speed up epidemic control in developing countries. 

AstraZeneca vaccine on children first clinical trial

The World Health Organization (WHO) has approved the use of two versions of the vaccine, developed by South Korea's SK Bioscience and India's Serum Institute of India.

The use of the vaccine was formally approved following the recommendation of experts from the WHO's Strategic Advisory Group and will be available to all adults over the age of 18.

The World Health Organization's recommendations differ from those of some European countries where the vaccine is not recommended for the elderly. 

Many developing countries have not yet received vaccine doses, while millions of people in rich countries have been vaccinated.

On the other hand, there are growing concerns that new strains of the virus could affect the effectiveness of vaccines.

The use of the AstraZeneca vaccine on a new strain of the coronavirus discovered in South Africa has had little effect, leading to a ban on the use of the vaccine there.

Head of the World Health Organization's vaccination division, said countries were excited about the AstraZeneca vaccine, but at the same time, they were asking relevant questions about what the evidence proves and what doesn't.

"There are plausible reasons why we believe this could prevent the seriousness of the code," he said.

The vaccine was approved by the World Health Organization (WHO) for the global vaccine campaign so that it could deliver the vaccines to the participating countries.

The vaccine has previously been approved for use in the European Union, the United Kingdom, Pakistan, India, and a few other countries. 

For more details click here.